Analyst Recommendations

Lake Street analyst issues BUY recommendation for CVRX on October 30, 2024 08:40AM ET. The previous analyst recommendation was Buy.CVRX was trading at $13.04 at issue of the...

October 30, 2024   CVRX 29.89%

Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for UDMY on October 30, 2024 08:38AM ET. The previous analyst recommendation was Overweight.UDMY was trading at $8.01 at issue of the...

October 30, 2024   UDMY -3.25%

Lake Street analyst issues BUY recommendation for OPRA on October 30, 2024 08:38AM ET. The previous analyst recommendation was Buy.OPRA was trading at $18.2 at issue of the...

October 30, 2024   OPRA 0.76%

Oppenheimer analyst issues OUTPERFORM recommendation for V on October 30, 2024 08:37AM ET. The previous analyst recommendation was Outperform.V was trading at $291.16 at issue of the analyst...

October 30, 2024   V 2.97%

Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for BMRN on October 30, 2024 08:35AM ET. The previous analyst recommendation was Overweight.BMRN was trading at $67 at issue of the...

October 30, 2024   BMRN -4.31%

Cantor Fitzgerald analyst issues NEUTRAL recommendation for SNAP on October 30, 2024 08:33AM ET. The previous analyst recommendation was Neutral.SNAP was trading at $12 at issue of the...

October 30, 2024   SNAP 15.54%

BMO Capital analyst issues MARKET PERFORM recommendation for PYPL on October 30, 2024 08:50AM ET. The previous analyst recommendation was Market Perform.PYPL was trading at $78.945 at issue...

October 30, 2024   PYPL -2.42%

BMO Capital analyst issues OUTPERFORM recommendation for MCD on October 30, 2024 08:47AM ET. The previous analyst recommendation was Outperform.MCD was trading at $293.71 at issue of the...

October 30, 2024   MCD -1.20%

BMO Capital analyst issues UNDERPERFORM recommendation for INCY on October 30, 2024 08:45AM ET. The previous analyst recommendation was Underperform.INCY was trading at $73.02 at issue of the...

October 30, 2024   INCY 0.54%

Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for HRMY on October 30, 2024 08:44AM ET. The previous analyst recommendation was Overweight.HRMY was trading at $35.02 at issue of the...

October 30, 2024   HRMY -17.96%